SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-01BIOXSCHEDULE 13D/AAmendment to Schedule 13D for Bioceres Crop Solutions Corp.MEDIUM
This Amendment No. 1 to Schedule 13D, filed by Jasper Lake Ventures One LLC and Noah Kolatch, updates the ownership and intentions regarding the ordinary shares of Bioceres Crop Solutions Corp. As of September 30, 2025, the reporting persons hold or have the right to receive 7,482,961 ordinary shares, representing appr...
2025-10-01SPRYSCHEDULE 13D/AAmendment No. 3 to Schedule 13D/A for ARS Pharmaceuticals, Inc.MEDIUM
This Amendment No. 3 to Schedule 13D/A, filed by RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., reports a Credit Agreement entered into by ARS Pharmaceuticals, Inc. and its subsidiaries. The Credit Agreement provides for up to $250.0 million in term loans to fund resea...